Integrated Cardiac Safety
Assessment Methodologies for Noncardiac Drugs in Discovery, Development, and Postmarketing Surveillance
Samenvatting
The serious nature of cardiovascular adverse drug reactions occurring in patients makes assessment of a drug's cardiac safety profile a high priority during both development and post-approval monitoring.

